Why CRISPR Therapeutics Could Skyrocket: A Must-Buy Stock for 2024!

Sdílet
Vložit
  • čas přidán 5. 09. 2024
  • Greetings, fellow investors! Welcome back to ShareTreck. I'm Raj, today I am sharing evolving thesis around CRISPR Therapeutics. Please let me know what you think?
    Well this is my personal opinion, not financial advice.
    JOIN THE CHANNEL AS A MEMBER:
    Please check out the membership offering and join me in the exciting new chapter for ShareTreck, Thanks for your support so far and looking forward to much more. Use the link below to join or click on the Join button on the bottom left of your screen or copy the link below to your browser address bar and press enter.
    / @sharetreck
    Please subscribe: / @sharetreck
    The videos in this channel should not be construed as financial advice. Always make sure to do your own due diligence and research.
    Please do not trade or invest based on this video. Information provided in this video is not investment advice and is for entertainment purposes only.
    In case of coverage of pharma companies, disease and therapy details are derived from news articles and publications by companies or research organizations. I am not a doctor but am only facilitating dissemination of published information.

Komentáře • 27

  • @simonposener7601
    @simonposener7601 Před 3 měsíci +2

    Hi Raj,... I certainly enjoy CRSP, as I have a fairly large investment... Also, PACB, although a current big loser... I am somewhat hopeful that this technology can be important.. and I value your opinion, insights and analysis.. Also, besides big tech.. how about CMPS or NIO, as somewhat emerging sectors.... :)

    • @ShareTreck
      @ShareTreck  Před 3 měsíci +1

      Thanks Simon. I will add the other tickers. I’ll want to curate the watch list to include viewers choice.

  • @Inf
    @Inf Před 3 měsíci +1

    I love that cash position as well Raj
    Enough cash and good well capitalized partners until it gets more sales.
    Nice incorporating macro Raj and that equity dilution
    Definitely rate cut by Sept or nov (priced in)

  • @tatamarcopolo
    @tatamarcopolo Před 3 měsíci +1

    Thank you Raj for sharing your insights. Could make analysis ALNY. It’s valuation and it’s pipeline development

    • @ShareTreck
      @ShareTreck  Před 3 měsíci

      Hi Kiran, I will take a look at it. But the core problem is that only CRSP videos get decent viewership. Why not the others? Any insights could help.

  • @joshs8860
    @joshs8860 Před 3 měsíci +1

    Hey Raj! I think we all suspect CRSP to do well over time. I always love your journalistic/news sessions. Perhaps a regular market news, economic news, general updates. Its a touch of work, but something regular that Raj could turn into bread and butter. With the tenacity you've shown Raj you got to take some of the decision out of it. A daily market news, economics news, and or macro economic considerations. IE: Raj: I just found out that pork belly supplies have been stranded on trains in July in South China...or: Possible concerns with Potash supply possibly creating a warning to some international agricultural centers. Or even...why did Nuscale jump 40 percent on such and such a day. Its tough work, but Raj ain't scared. I think with my ADHD, having some regular SOP that I could hunt and fill in just to have some steadyness...brute force is easier than creating new structures.

    • @ShareTreck
      @ShareTreck  Před 3 měsíci +1

      Thanks Josh, all good ideas and I will put it into my list. This sure helps a lot!! Have a great day Josh!!

    • @joshs8860
      @joshs8860 Před 3 měsíci

      @@ShareTreck Thanks Raj!

  • @Inf
    @Inf Před 3 měsíci +1

    I'm watching it Raj :^)

  • @chrisp3083
    @chrisp3083 Před 3 měsíci +1

    Hi Raj, It looks like it made a higher low this last pullback.

    • @ShareTreck
      @ShareTreck  Před 3 měsíci

      Yes. The next few days are critical. If EU cuts rates, we should see more traction IMHO.

  • @FutupPHD
    @FutupPHD Před 3 měsíci +1

    When do you think we will start seeing some revenue from casgevy? I feel we need to see some revenue to see a boost in this stock.

    • @ShareTreck
      @ShareTreck  Před 3 měsíci

      I suspect we will see it in Q2 earnings.

  • @kentkjrgaardjensen4304
    @kentkjrgaardjensen4304 Před 3 měsíci +1

    Hey Raj. I know you are interested in AI and right now palantir is really hot and it is an amazing company which finally reached positive cash flow a little over a year ago. I think your viewers are more into gene therapy but might be worth testing palantir for your AI viewers :) of course only if you are interrested in palantir yourself. Never do content you don't like to do just for th views 😊

    • @ShareTreck
      @ShareTreck  Před 3 měsíci

      Thanks Kent. I have Palantir in my portfolio. I will surely take your advice and test it out. Hey, thanks a lot 😊 👍

    • @kentkjrgaardjensen4304
      @kentkjrgaardjensen4304 Před 3 měsíci +1

      @@ShareTreck great! I think people right now are going for stocks with positive cash flow /risk off stocks. When rate cuts are coming I think you will see a surge in view on those risk on stocks again 😊

    • @ShareTreck
      @ShareTreck  Před 3 měsíci

      @kentkjrgaardjensen4304 💯

    • @ShareTreck
      @ShareTreck  Před 3 měsíci

      @kentkjrgaardjensen4304 hi Kent, I am at a crossroad. I want to get your advice on some channel decision. Is it possible to get on a zoom call? Raj@sharetreck.com

    • @kentkjrgaardjensen4304
      @kentkjrgaardjensen4304 Před 3 měsíci

      @@ShareTreck hi Raj. Can't do zoom but you are welcome to send me an email and I would be happy to give feedback 😊 can send a message to your email so you have mine? Just so I don't post mine In public